Identification of HSPG2 as a bladder pro-tumor protein through NID1/AKT signaling
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Heparan sulfate proteoglycan 2 (HSPG2) promotes bladder cancer progression and chemotherapy resistance by activating the NID1/AKT pathway. Targeting HSPG2 offers a potential therapeutic strategy for bladder cancer treatment.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Research
Background
- Heparan sulfate proteoglycans (HSPGs) are crucial in tumor progression.
- Heparan sulfate proteoglycan 2 (HSPG2) is implicated in various cancers.
Purpose Of The Study
- To investigate the role of HSPG2 in bladder cancer progression.
- To elucidate the molecular mechanisms underlying HSPG2's function in bladder tumors.
Main Methods
- Single-cell RNA sequencing and transcriptome analysis of patient data (GEO database).
- Analysis of HSPG2 expression and survival outcomes using Sanger tools and cBioPortal.
- In vitro (cell lines) and in vivo (mouse models) experiments to assess proliferation, migration, and chemosensitivity.
- Evaluation of Nidogen-1 (NID1)/protein kinase B (AKT) signaling pathway activation.
Main Results
- HSPG2 was significantly upregulated in bladder tumors, correlating with poor prognosis.
- HSPG2 overexpression enhanced tumor cell proliferation and chemotherapy resistance.
- HSPG2 upregulated NID1, activating the AKT pathway and promoting tumor growth.
Conclusions
- HSPG2 plays a critical pro-tumor role in bladder cancer via the NID1/AKT signaling axis.
- HSPG2 represents a potential therapeutic target for bladder cancer treatment.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...